Is it actually growing, and how fast?
A top-tier grower that's turning around. Earnings are outgrowing revenue, a sign of improving margins and operating leverage. Quality of growth is high even if the top line is moderate. The strongest point: revenue is set to grow 27%/yr over the next 3 years, ahead of most of the market. The one thing to watch: revenue has shrunk over the past 3 years.
Is the market behind it right now?
Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The strongest point: strong recent results. The one thing to watch: the stock is underperforming over the past month and over three months.
Are you paying a fair price for it?
A fairly-priced stock. Neither multiples nor yields stand out strongly. Value investors may want to wait for a better entry or look elsewhere. The strongest point: its forward P/E of 18x is 18% below that median, and its three-year P/E of 12x is 43% below. The one thing to watch: free cash flow is negative.
Is the business high-quality and durable?
A middle-of-the-pack business on quality. Margins, returns and balance sheet sit around the market average. Workable, but not a standout on business quality. The strongest point: best on EBITDA margin at 33%, better than 70% of companies worldwide. The one thing to watch: free cash flow is negative.
How does this stock score across Bastion factors?
Billed annually at $249/year $348